An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.

Informations projet

VasQ

N° de convention de subvention: 710564

DOI

10.3030/710564

Projet clôturé

Date de signature de la CE 25 Novembre 2015

Date de début 1 Decembre 2015

Date de fin 31 Mars 2016

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total

€ 71 429,00

Contribution de l’UE

€ 50 000,00

Coordonné par

LAMINATE MEDICAL TECHNOLOGIES LTD
Israel

Periodic Reporting for period 1 - VasQ (An innovative external brace to ensure patency and maturity of arteriovenous fistulas in haemodialysis patients.)

Période du rapport: 2015-12-01 au 2016-03-31

Résumé du contexte et des objectifs généraux du projet

During the Phase 1 feasibility study Laminate undertook a deep study of the technical aspects of its VasQ device including industrialisation and benefits. Business elements examined included deep market analysis and an in-depth customer/end-user study. The activities contributed to the development of a plan to bring the medical device to market and the decision to apply for Phase 2 funding through the SME Instrument.

Travail effectué depuis le début du projet jusqu’à la fin de la période considérée dans le rapport et principaux résultats atteints jusqu’à présent

Partners were investigated and engaged for carrying out production of the device. The type of clinical trial required to commercialise the device was identified and elaborated. Users were contacted and accounted for in the report. A clinical synopsis for the trial was prepared. The value chain was filled out by the addition of the partners to the consortium.

Progrès au-delà de l’état des connaissances et impact potentiel prévu (y compris l’impact socio-économique et les conséquences sociétales plus larges du projet jusqu’à présent)

The only medical device in its field which improves the maturation/usability rate of arteriovenous fistulas over time.

The device.